Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1001026-56-7

Post Buying Request

1001026-56-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1001026-56-7 Usage

General Description

2,4-Difluorobenzylsulfonamide is a chemical compound that belongs to the organofluorine group of compounds. It is a sulfonamide derivative, which contains a sulfonamide functional group and two fluorine atoms attached to a benzene ring. 2,4-Difluorobenzylsulfonamide has been studied for its potential use in pharmaceuticals and agrochemicals due to its ability to act as a potential building block for the synthesis of various biologically active molecules. Additionally, 2,4-Difluorobenzylsulfonamide has been investigated for its potential as an antimicrobial agent. Its unique structure and properties make it an important chemical for further research and development in the fields of medicine and agriculture.

Check Digit Verification of cas no

The CAS Registry Mumber 1001026-56-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,0,1,0,2 and 6 respectively; the second part has 2 digits, 5 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1001026-56:
(9*1)+(8*0)+(7*0)+(6*1)+(5*0)+(4*2)+(3*6)+(2*5)+(1*6)=57
57 % 10 = 7
So 1001026-56-7 is a valid CAS Registry Number.

1001026-56-7Relevant articles and documents

Optimization of P2Y12 Antagonist Ethyl 6-(4-((Benzylsulfonyl)carbamoyl)piperidin-1-yl)-5-cyano-2-methylnicotinate (AZD1283) Led to the Discovery of an Oral Antiplatelet Agent with Improved Druglike Properties

Kong, Deyu,Xue, Tao,Guo, Bin,Cheng, Jianjun,Liu, Shunyin,Wei, Jianhai,Lu, Zhengyu,Liu, Haoran,Gong, Guoqing,Lan, Tian,Hu, Wenhao,Yang, Yushe

, p. 3088 - 3106 (2019/04/01)

P2Y12 antagonists are widely used as antiplatelet agents for the prevention and treatment of arterial thrombosis. Based on the scaffold of a known P2Y12 antagonist AZD1283, a series of novel bicyclic pyridine derivatives were designed and synthesized. The cyclization of the ester substituent on the pyridine ring to the ortho-methyl group led to lactone analogues of AZD1283 that showed significantly enhanced metabolic stability in subsequent structure-pharmacokinetic relationship studies. The metabolic stability was further enhanced by adding a 4-methyl substituent to the piperidinyl moiety. Compound 58l displayed potent inhibition of platelet aggregation in vitro as well as antithrombotic efficacy in a rat ferric chloride model. Moreover, 58l showed a safety profile that was superior to what was observed for clopidogrel in a rat tail-bleeding model. These results support the further evaluation of compound 58l as a promising drug candidate.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1001026-56-7